These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6440937)

  • 41. Slow eye movements in spinocerebellar degeneration.
    Singh BM; Ivamoto H; Strobos RJ
    Am J Ophthalmol; 1973 Aug; 76(2):237-40. PubMed ID: 4725008
    [No Abstract]   [Full Text] [Related]  

  • 42. [An update on neurochemistry and pharmacological therapy of the cerebellar ataxias].
    Gazulla J
    Rev Neurol; 2007 Jul 1-15; 45(1):31-41. PubMed ID: 17620264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Thyroliberin and its importance in thyroid diseases].
    Vakulenko AD
    Probl Endokrinol (Mosk); 1982; 28(5):82-7. PubMed ID: 6815638
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
    J Neuroimaging; 2011 Apr; 21(2):132-7. PubMed ID: 19674246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Letter: T.R.H. in psychoses.
    Dimitrikoudi M; Hanson-Norty E; Jenner FA
    Lancet; 1974 Mar; 1(7855):456. PubMed ID: 4131456
    [No Abstract]   [Full Text] [Related]  

  • 46. Letter: Intravenous thyrotrophin-releasing hormone in Parkinson's disease.
    McCaul JA; Cassell KJ; Stern GM
    Lancet; 1974 Apr; 1(7860):735. PubMed ID: 4132453
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral protirelin (T.R.H.) in depression.
    Sugerman AA; Swartzburg M; Mueller PS; Rochford J
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):94-8. PubMed ID: 812670
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of thyrotropin-releasing hormone in chronic schizophrenic patients.
    Kobayashi K; Nakaoka K; Tsuji H; Shohmori T
    Acta Med Okayama; 1980 Sep; 34(4):263-73. PubMed ID: 6452029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter: Comparison of T.R.H., L.H.-R.H., and placebo in depression.
    Benkert O; Martschke D; Gordon A
    Lancet; 1974 Nov; 2(7889):1146. PubMed ID: 4139447
    [No Abstract]   [Full Text] [Related]  

  • 50. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.
    Mitsumoto H; Salgado ED; Negroski D; Hanson MR; Salanga VD; Wilber JF; Wilbourn AJ; Breuer AC; Leatherman J
    Neurology; 1986 Feb; 36(2):152-9. PubMed ID: 3080695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Choline chloride in the treatment of ataxia.
    Livingstone IR; Mastaglia FL
    Br Med J; 1979 Oct; 2(6195):939. PubMed ID: 391326
    [No Abstract]   [Full Text] [Related]  

  • 52. Phase relations between rhythmical forearm movements and breathing in cerebellar impaired patients.
    Ebert D; Hefter H
    Adv Exp Med Biol; 2001; 499():417-24. PubMed ID: 11729918
    [No Abstract]   [Full Text] [Related]  

  • 53. Thyrotropin-releasing hormone for prevention of neonatal respiratory disease.
    Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J
    Lancet; 1995 Jun; 345(8964):1572. PubMed ID: 7791458
    [No Abstract]   [Full Text] [Related]  

  • 54. [Physostigmine in treatment of cerebellar ataxia].
    Aschoff JC; Kailer NA; Walter K
    Nervenarzt; 1996 Apr; 67(4):311-8. PubMed ID: 8684510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of the route of administration on thyrotropin-releasing hormone concentration in the mouse brain.
    Mitsuma T; Nogimori T
    Experientia; 1983 Jun; 39(6):620-2. PubMed ID: 6406262
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
    Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
    Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter: Thyrotrophin-releasing hormone in depression.
    Hall R; Hunter PR; Price JS; Mountjoy CQ
    Lancet; 1975 Jan; 1(7899):162. PubMed ID: 46071
    [No Abstract]   [Full Text] [Related]  

  • 58. A cerebellar ataxic rat produced by kainic acid and changes in concentration and turnover rates of catecholamines in discrete brain regions.
    Niimi M; Takahara J; Aoki Y; Fujino H; Ofuji T
    Acta Med Okayama; 1982 Jun; 36(3):223-7. PubMed ID: 7113747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Letter: Thyrotrophin-releasing hormone in depression.
    Mountjoy CQ; Hall R
    Lancet; 1974 Aug; 2(7877):415. PubMed ID: 4137018
    [No Abstract]   [Full Text] [Related]  

  • 60. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.
    Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J; Davis DJ; Padbury JF; Phibbs RH; Parer JT; Hart MC; Mannino FL; Sawai SK
    N Engl J Med; 1998 Feb; 338(8):493-8. PubMed ID: 9468465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.